Authors:
E-mail: Сведения доступны для зарегистрированных пользователей.
Heading: Clinical guidelines
UDC: 616.155.294(048.8)
Link: Clinical Physiology of Blood Circulaiton. 2018; 2 (2): 102-111
Quote as: Kupryashov A.A., Khicheva G.A. (compilers) Heparin-induced thrombocytopenia: the review of clinical recommenda- tions. Cardiovascular Surgery News. 2018; 2 (2): 102–11 (in Russ.). DOI: 10.24183/2588-0284-2018-2-2-102-111
Received / Accepted: May 11, 2018 / May 17, 2018
We present the review of clinical guidelines of American College of Chest Physicians (ACCP) on prognostication, diagnosis, treatment and prevention of heparin-induced thrombocytopenia. The classification of the quality of evidence and grade strength of recommendations is given, as well as the results of their critical appraisal in comparison with other existing guidelines with the help of Appraisal of Guidelines for Research & Evaluation II (AGREE II) instrument.
Linkins L.A., Dans A.L., Moores L.K., Bona R., Davidson B.L., Schulman S., Crowther M. Treatment and prevention of heparin-induced thrombocytopenia: antithrombotic therapy and prevention of thrombosis. 9th ed. American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012; 141 (2 Suppl.): e495S–530S. DOI:
Wang Y., Ye Z.K., Li J.F., Cui X.L., Liu L.H. Heparin-induced thrombocytopenia: a critical appraisal of clinical practice guidelines with the AGREE II instrument. Thromb Res. 2018; 166: 10–8. DOI: